Glewis S, Alexander M, Khabib MNH, Brennan A, et al. A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing. Br J Cancer 2022;127:126-136.
PMID: 35306539